Greg Norden is the former Chief Financial Officer of Wyeth. Mr. Norden also serves on the Boards of Zoetis, the leading animal health company; Royalty Pharma, a leading funder of innovation across the biopharmaceutical industry; and Praxis, a clinical-stage biopharmaceutical company. In addition, Mr. Norden is the Managing Director of G9 Capital Group, LLC, which invests in early-stage ventures and provides corporate finance advisory services. Mr. Norden is a former director of Human Genome Sciences, NanoString, Univision and WelchAllyn.